Shares are on the rise in cancer technology company Physiomics after it announced a contract with a major global top 10 pharmaceutical client. The company's shares rose 10% to 7.98p by mid-afternoo...
Original Article: Physiomics shares jump as new 'virtual tumour' contract signed
NEXT ARTICLE